drugset / Trial / NCT07260175
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
Phase 2
Recruiting
40 enrolled
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Servier Affaires Médicales · collabServier Deutschland GmbH · collab
NaSingle-groupOpen-labelTreatment
Summary
This study trial is a prospective, multicentre, exploratory, single-arm, open-label phase II study to evaluat ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma
Timeline
- Start
- 2025-11-18
- Primary completion
- 2030-12
- Completion
- 2031-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivosidenib | Small molecule | 500 mg | — |